Aprepitant reduces inflammatory markers in HIV infected cART treated and cART naive adults

Spitsin, S; Pappa, V; Velasquez, S; Rappaport, J; Douglas, SD

JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2018; 13 (): S82